DXCM News & Events

DexCom announced through ongoing quality and accounting reviews it recently identified certain lots of Dexcom G7 sensors originally designated as scrap and intended for destruction were stolen during the destruction process, then sold by third parties. Scrapping limited amounts of sensors that do not meet Dexcom standards is a routine part of the company's quality control process. Sensors identified as scrap are sent to a third-party vendor for destruction and recycling. At this time, Dexcom has identified two lots of Dexcom G7 sensors that were stolen, sold and used by some customers. Dexcom traced sales of this stolen product back to Pharmsource, who is not an authorized Dexcom distributor but supplies some independent pharmacies and DME distributors in the United States. Pharmacies that purchased product from Pharmsource should take extra care to review their inventory. Dexcom is notifying customers directly across numerous communication channels. This issue primarily impacts the US, therefore communication to US customers will precede communication to OUS customers.

DexCom announced Dexcom Flex, a new CGM system designed specifically for adults with Type 2 diabetes who are not using intensive insulin therapy. The new system will be available in Germany soon. The company said, "Dexcom Flex is made for people using basal insulin, oral medications or GLP-1 receptor agonists, expanding access to CGM technology for a broader Type 2 diabetes population. Dexcom Flex reflects the company's commitment to placing people at the centre of the product design process and creates a personalised diabetes guidance experience, rather than offering a one-size-fits-all approach."